[Intended use] This product is used for in vitro qualitative detection of Brucella IgM/IgG antibodies in human serum/plasma/whole blood samples. Suitable for screening and auxiliary diagnosis of suspected Brucella infection population. The incubation period of brucellosis is generally 1-3 weeks. The course of the disease is acute within 3 months; 3-6 months is the subacute phase; The chronic phase lasts for more than 6 months and all cases show positive serological reactions. In the early stages of infection, specific IgM antibodies begin to appear, followed by specific IgG antibodies, which continue to increase with the progression of the disease; Specific IgM antibodies appear later in some acute phase patients, and specific IgG antibodies persist after recovery. When the disease recurs, the titer of specific IgG antibodies usually increases rapidly, while specific IgM antibodies may or may not increase. In long-term cases, the titer of specific IgM antibodies gradually decreases, while specific IgG antibodies persist. The laboratory examination methods for Brucella include preliminary screening tests, including Tiger Red Plate Agglutination Test, Colloidal Gold Immunochromatography Test (GICA), Enzyme Linked Immunosorbent Assay (ELISA), and Brucella culture smear Gram staining; Confirmation tests: including standard tube agglutination test (SAT), anti human immunoglobulin test (Coomb's), complement binding test (CFT), and isolation, culture, and identification of Brucella. The detection methods of IgM and IgG can assist in distinguishing active infections from previous infections. The diagnosis of brucellosis should be comprehensively judged based on epidemiological history, clinical manifestations, and laboratory test results.
[Product Specification] 1 pcs/box
Contact us
Copyright © 2024 Xinjiang Yufo Biotech Co., Ltd. All right reserved. Commercial ICP Licence (Xinjiang) No. 2025-0012